Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-18546.20%
↓ 437% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
-3455.80%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -18546.20% | -578.4% |
| 2024 | -2733.63% | -35.3% |
| 2023 | -2019.96% | +54.3% |
| 2022 | -4420.87% | -211.2% |
| 2021 | -1420.77% | -130.9% |
| 2020 | -615.30% | +55.7% |
| 2019 | -1390.06% | -82.6% |
| 2018 | -761.20% | +6.7% |
| 2017 | -816.27% | +55.5% |
| 2016 | -1833.75% | - |